131 related articles for article (PubMed ID: 24132737)
1. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome.
Hrabe JE; Byrn JC; Button AM; Zamba GK; Kapadia MR; Mezhir JJ
J Surg Oncol; 2014 Feb; 109(2):117-21. PubMed ID: 24132737
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer prognosis among patients with inflammatory bowel disease.
Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
[TBL] [Abstract][Full Text] [Related]
3. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.
Ali RA; Dooley C; Comber H; Newell J; Egan LJ
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283
[TBL] [Abstract][Full Text] [Related]
4. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study.
Gearhart SL; Nathan H; Pawlik TM; Wick E; Efron J; Shore AD
Dis Colon Rectum; 2012 Mar; 55(3):270-7. PubMed ID: 22469793
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.
Axelrad J; Kriplani A; Ozbek U; Harpaz N; Colombel JF; Itzkowitz S; Holcombe RF; Ang C
Clin Colorectal Cancer; 2017 Sep; 16(3):e205-e210. PubMed ID: 27742264
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
7. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
[TBL] [Abstract][Full Text] [Related]
8. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal P; Sonnenberg A
Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
[TBL] [Abstract][Full Text] [Related]
10. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
11. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study.
Thicoïpé A; Laharie D; Smith D; Chabrun E; Rullier A; Poullenot F; Rullier E; Denost Q
Int J Colorectal Dis; 2018 Jul; 33(7):963-966. PubMed ID: 29675590
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.
Reynolds IS; O'Toole A; Deasy J; McNamara DA; Burke JP
Int J Colorectal Dis; 2017 Apr; 32(4):443-451. PubMed ID: 28078433
[TBL] [Abstract][Full Text] [Related]
13. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
[TBL] [Abstract][Full Text] [Related]
15. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
Bogach J; Pond G; Eskicioglu C; Seow H
Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
[TBL] [Abstract][Full Text] [Related]
17. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
Bernstein CN; Nugent Z; Blanchard JF
Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
[TBL] [Abstract][Full Text] [Related]
18. Disease severity does not affect the interval between IBD diagnosis and the development of CRC: results from two large, Dutch case series.
Mooiweer E; Baars JE; Lutgens MW; Vleggaar F; van Oijen M; Siersema PD; Kuipers EJ; van der Woude CJ; Oldenburg B
J Crohns Colitis; 2012 May; 6(4):435-40. PubMed ID: 22398065
[TBL] [Abstract][Full Text] [Related]
19. Use of surveillance colonoscopy in medicare patients with inflammatory bowel disease prior to colorectal cancer diagnosis.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Digestion; 2014; 90(1):58-62. PubMed ID: 25196002
[TBL] [Abstract][Full Text] [Related]
20. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
